Skip to Content

Frequently Searched

Supported by

MIOP Residency Program: An Innovative & Direct Path To A Successful Career in Oncology Pharmacy

The NCODA Medically-Integrated Oncology Pharmacy (MIOP) Residency Program provides new pharmacy graduates and practicing pharmacists an exclusive opportunity to engage in a comprehensive 1-year training program at a medically integrated pharmacy designed to prepare participants for a successful career in oncology pharmacy. NCODA is working with cancer centers throughout the United States to provide the framework and accreditation for this residency program.

An Innovative & Direct Path To A Thriving Career in Oncology Pharmacy

The NCODA Medically-Integrated Oncology Pharmacy (MIOP) Residency Program provides new pharmacy graduates and practicing pharmacists an exclusive opportunity to engage in a comprehensive 1-year training program at a medically integrated pharmacy designed to prepare participants for a successful career in oncology pharmacy. NCODA is working with cancer centers throughout the United States to provide the framework and accreditation for this residency program.

Apply Today

OUR PURPOSE

To help participants gain and develop comprehensive skills and knowledge to treat cancer patients with the highest level of care. Upon completion of this residency program, graduates will be highly committed, lifelong learners that are able to adapt to various oncology practice settings. Graduates will also become empowered healthcare leaders focused on innovating the continuity of cancer care.

WHAT IS A MEDICALLY-INTEGRATED PHARMACY?

A dispensing pharmacy within an oncology center of excellence that promotes a patient-centered, multidisciplinary team approach. It is an outcome-based collaborative and comprehensive model that involves oncology healthcare professionals and other stakeholders who focus on the continuity of coordinated quality care and therapies for cancer patients.
Learn More

Program Benefits

The NCODA MIOP Residency offers a unique, real-world training experience that builds advanced clinical, operational, and leadership skills within a medically integrated oncology pharmacy setting. Residents gain direct exposure to oncology care, benefit from mentorship, and graduate fully prepared to make an immediate impact in a high-demand specialty. Practices that partner with NCODA are leading the way in investing in the future of quality cancer care. The program brings motivated, well-trained pharmacists into your team, enhances care delivery, and strengthens your commitment to professional development and innovation within the medically integrated model.
  • Direct path to a career in oncology clinical pharmacy
  • Innovative streamlined training in Medically-Integrated Oncology Pharmacy
  • Comprehensive oncology education and training at top cancer centers
  • Flexibility of tailored rotation opportunities
  • Publication and presentation opportunities
  • Network at oncology conferences
  • Collaborate with NCODA’s network of practices
  • Competitive salary

 

Have a Question?

 

  • Establish an accredited residency program at cancer center
  • Custom tailored residency accreditation from NCODA
  • Access to curated residency applicant pool
  • Expand research opportunities
  • Leadership development pipeline (resident –> future practice leader)
  • Collaborate with NCODA practices on residency opportunities

 

Start an Accredited Residency

  • Completion of pharmacy degree (ACPE-accredited pharmacy school)
  • Eligible to work in the United States
  • Curriculum vitae
  • Official transcript(s)
  • Letter of intent
  • 2 letter of recommendation contacts
  • Collaborative
  • Strong verbal and written communication skills
  • Strong interpersonal skills
  • Proficient with Microsoft Office
  • Self-starter and able to work independently with minimal supervision
  • Eligible for current state licensure based on residency location
  • Application Opens: 11/03/25
  • Application Due: 01/30/26
  • Interview Period: 11/03/25 – 02/27/26
  • Selection: 03/02/26 – 04/06/26
  • Start Date: 06/22/26 – 07/06/26
  • $32 USD Application Fee

 

*Dates are subject to change per program need.

Participating Programs

    • Florida Cancer Specialists & Research Institute (Fort Myers, FL)
    • Texas Oncology (Dallas/Fort Worth, TX)

*Additional programs to be announced. 1-2 residents will be selected per practice site.

Future leaders in pharmacy

PROGRAM OVERVIEW

The MIOP Residency Program includes 4 specific rotations:

  • Oral Outpatient Oncology Practice (5 Months)
  • IV/Infusion Oncology Practice (5 Months)
  • Pharmacy Business/Leadership (2 Months)
  • Research (12 Months |Longitudinal | Finding presented at NCODA Spring Forum)

The goals and competencies of each rotation are developed by the rotation preceptors and approved by NCODA’s Residency Review Committee. The activities and projects that each resident is involved in per rotation will be determined by the Rotation Preceptor and resident prior to the rotation start date, in accordance with NCODA’s MIOP Residency Manual.

Brandon Dyson, PharmD, BCOP, BCPS Pharmacy Area Manager and Nathan Uk, PharmD, MIOP Pharmacy Resident 2024-2025 | Texas Oncology

“My time at Texas Oncology’s MIOP Residency through NCODA has been incredible and full of rewarding experiences. I appreciate the hands-on approach for residency and cannot imagine a better experience for those wanting to go into Oncology Pharmacy. Each project offered to me is meaningful and I can proudly say I am passionate about every one that I have done.

Nathan Uk, PharmD | MIOP Pharmacy Resident 2024-2025 | Texas Oncology

MIOP Residency Program is led by:

MUSTAFA ABACIOGLU, MPHARM

Manager of Membership & Professional Development – Students | Residents | Fellows

About Mustafa